12/06/2015 - 13:20
CHICAGO – Anastrozole may top tamoxifen in reducing the risk of disease recurrence in postmenopausal ductal carcinoma in situ (DCIS), particularly in younger women, but which drug holds a cost...
Field of Interest: Pulmonology
Categories:
News Feed: Internal Medicine News - Pulmonology